Healthcare - Biotechnology - NASDAQ - CA
$ 39.61
-7.78 %
$ 241 M
Market Cap
-62.87
P/E
BALANCE SHEET
6.88 M
ASSETS
281 K
LIABILITIES
6.6 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Bright Minds Biosciences Inc.
| Current Assets | 6.81 M |
| Cash & Short-Term Investments | 6.75 M |
| Receivables | 0 |
| Other Current Assets | 64.7 K |
| Non-Current Assets | 66.4 K |
| Long-Term Investments | 0 |
| PP&E | 66.4 K |
| Other Non-Current Assets | 0 |
| Current Liabilities | 281 K |
| Accounts Payable | 182 K |
| Short-Term Debt | 73.5 K |
| Other Current Liabilities | 25 K |
| Non-Current Liabilities | 0 |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Sep-2023 | Sep-2022 | Sep-2021 | Sep-2020 | Sep-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 6.7 | 11.6 | 19.8 | 0.8 | 80 K |
| Short Term Investments | 86.2 K | 86.2 K | 86.2 K | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 27.7 K | 0.2 | 0.2 | 78.3 K | 0 |
| Total Current Assets | 6.8 | 11.9 | 20.0 | 0.9 | 80 K |
| PP&E | 66.4 K | 0.1 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 2 000.0 | 2 | 2 K |
| Goodwill | 0 | 0 | (2 000.0) | 2 K | 0 |
| Long Term Investments | 0 | 0 | 33.7 K | 1 K | 82 K |
| Other Long Term Assets | 0 | 0 | 33.7 K | 1 K | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 6.9 | 12.1 | 20.0 | 0.9 | 0.2 |
| LIABILITIES | |||||
| Accounts Payable | 0.2 | 1.2 | 0.6 | 0.1 | 36.7 K |
| Short Term Debt | 73.5 K | 67.9 K | 0 | 0 | 0 |
| Other Current Liabilities | 25 K | 0.2 | 42 K | 12.5 K | 0 |
| Total Current Liabilities | 0.3 | 1.5 | 0.6 | 0.2 | 36.7 K |
| Long Term Debt | 0 | 72 K | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 0.3 | 1.5 | 0.6 | 0.2 | 36.7 K |
| EQUITY | |||||
| Common Stock | 33.9 | 32.2 | 27.1 | 1.0 | 0.2 |
| Retained Earnings | (31.5) | (24.2) | (9.2) | (0.6) | 78.7 K |
| Other Accumulative Comprehensive Income/Loss | 3.4 | 2.5 | 1.6 | 0.2 | 82 K |
| Total Equity | 6.6 | 10.5 | 19.4 | 0.7 | 0.1 |
| Total Liabilities and Equity | 6.9 | 12.1 | 20.0 | 0.9 | 0.2 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 3.7 | 2.5 | 1.8 | 1.3 | 1.3 |